References
- Adams, D. H. and Lloyd, A. R. (1997). Chemokines: leucocyte recruitment and activation cytokines. Lancet. 349, 490-495 https://doi.org/10.1016/S0140-6736(96)07524-1
- Anjali, D., Huang, X. D. and Jeffrey, S. W. (1999). Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis. Lab Invest. 79, 837-847
- Blois, M. S. (1958). Antioxidant determinations by the use of a stable free radical. Nature 181, 1198-1744 https://doi.org/10.1038/1811199a0
- Boring, L., Gosling, J., Cleary, M. and Charo, I. F. (1998). Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897 https://doi.org/10.1038/29788
- Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 https://doi.org/10.1016/0003-2697(76)90527-3
- Buege, J. A. and Aust, S. D. (1978). Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310 https://doi.org/10.1016/S0076-6879(78)52032-6
- Carvalho, D., Savage, C. O., Black, C. M. and Pearson, J.D. (1996). IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J. Clin. Invest. 97, 111-119 https://doi.org/10.1172/JCI118377
- Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J. and Coughlin, S.R. (1994). Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. U. S. A. 91, 2752-2756 https://doi.org/10.1073/pnas.91.7.2752
- Dzau, V. J. (2001). Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37, 1047-1052 https://doi.org/10.1161/01.HYP.37.4.1047
- Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., Tsukamoto, Y., Yoshiyama, M., Takeuchi, K., Yoshikawa, J. and Becker, A. E. (2001). Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 17, 1955-1960
- Han, K. H., Chang, M. K., Boullier, A., Green, S. R., Li, A., Glass, C. K. and Quehenberger, O. (2000). Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 106, 793-802 https://doi.org/10.1172/JCI10052
- Han, K. H., Han, K. O., Green, S. R. and Quehenberger, O. (1999). Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J. Lipid Res. 40, 1053-1063
- Han, K. H., Ryu, J., Hong, K. H., Ko, J., Pak, Y. K., Kim, J. B., Park, S. W. and Kim, J. J. (2005). HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 22, 1439-1447
- Han, K. H., Tangirala, R. K., Green, S. R. and Quehenberger, O. (1998). Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler. Thromb Vasc Biol. 18, 1983-1991 https://doi.org/10.1161/01.ATV.18.12.1983
- Hong, Y., Hui, S. C., Chan, T. Y. and Hou, J.Y. (2002). Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30, 589-599 https://doi.org/10.1142/S0192415X02000612
- Kaikita, K., Hayasaki, T., Okuma, T., Kuziel, W. A., Ogawa, H. and Takeya, M. (2004). Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 165, 439-447 https://doi.org/10.1016/S0002-9440(10)63309-3
- Keidar, S., Kaplan, M., Hoffman, A. and Aviram, M. (1995). Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 115, 201-215 https://doi.org/10.1016/0021-9150(94)05514-J
- Ko, W. H., Yao, X. Q., Lau, C. W., Law, W. I., Chen, Z. Y., Kwok, W., Ho, K. and Huang, Y. (2000). Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol. 399, 187-196 https://doi.org/10.1016/S0014-2999(00)00339-3
- Ko, Y. J., Lee, J. S., Park, B. C., Shin, H. M. and Kim, J. A. (2007). Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells. Vascul. Pharmacol. 47, 189-196 https://doi.org/10.1016/j.vph.2007.06.004
- Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., Wang, S., Wu, J., Wang, Y., Li, Z., Liu, J. and Jiang, J. D. (2004). Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344-1351 https://doi.org/10.1038/nm1135
- Kurihara, T. and Bravo, R. (1996). Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J. Biol. Chem. 271, 11603-11607 https://doi.org/10.1074/jbc.271.20.11603
- Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H. and Huang, Y. (2001). Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 19, 234-244 https://doi.org/10.1111/j.1527-3466.2001.tb00068.x
- Lazzarino, D.A., de Diego, M., Hirschman, S.Z., Zhang, K.Y., Shaikh, S., Musi, E., Liaw, L. and Alexander, R.J. (2001). IL-8 and MCP-1 secretion is enhanced by the peptide-nucleic acid immunomodulator, Product R, in U937 cells and primary human monocytes. Cytokine 14, 234-239 https://doi.org/10.1006/cyto.2001.0867
- Li, D. Y., Zhang, Y. C., Philips, M. I., Sawamura, T. and Mehta, J. L. (1999). Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ. Res. 14, 1043-1049 https://doi.org/10.1161/01.RES.84.9.1043
- Morawietz, H., Rueckschloss, U., Niemann, B., Duerrschmidt, N., Galle, J., Hakim, K., Zerkowski, H.R., Sawamura, T. and Holtz, J. (1999). Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 31, 899-902
- Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C. and Laks, H. (1991). Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 88, 2039-2046 https://doi.org/10.1172/JCI115532
- Nickenig, G. and Bohm, M. (1997). Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia. Eur. J. Med. Res. 28, 285-289
- Park , B. C., Thapa, D., Lee, Y. S., Kwak, M. K., Lee, E. S., Choi, H. G., Yong, C. S. and Kim, J. A. (2007). 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. Eur. J. Pharmacol. 19, 193-197
- Penn, M. S. and Chisolm, G. M. (1994). Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 108 Suppl, S21-S29 https://doi.org/10.1016/0021-9150(94)90150-3
- Ramos, P., Gieseg, S. P., Schuster, B. and Esterbauer, H. (1995). Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J. Lipid Res. 36, 2113-2128
- Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T. and Masaki, T. (1997). An endothelial receptor for oxidized lowdensity lipoprotein. Nature 6, 73-77 https://doi.org/10.1038/386073a0
- Seino, Y., Ikeda, U., Takahashi, M., Hojo, Y., Irokawa, M., Kasahara, T. and Shimada, K. (1995). Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine 7, 575-579 https://doi.org/10.1006/cyto.1995.0078
- Sica, A., Wang, J. M., Colotta, F., Dejana, E., Mantovani, A., Oppenheim, J. J., Larsen, C. G., Zachariae, C. O. and Matsushima, K. (1990). Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol. 15, 3034-3038
- Takeya, M., Yoshimura, T., Leonald, E. J. and Takahashi, K. (1993). Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24, 534-539 https://doi.org/10.1016/0046-8177(93)90166-E
- Terkeltaub, R., Boisvert, W. A. and Curtiss, L. K. (1998). Chemokines and atherosclerosis. Curr. Opin. Lipidol. 9, 397-405 https://doi.org/10.1097/00041433-199810000-00003
- Yamahara, J., Kobayashi, G., Matsuda, H. and Fujimura, H. (1988). The vasorelaxant effect of evocarpine in isolated aortic strips:mode of action. Eur. J. Pharmacol. 155, 139-143 https://doi.org/10.1016/0014-2999(88)90411-6
- Yang, Y. Y., Hu, C. J., Chang, S. M., Tai, T. Y. and Leu, S. J. (2004). Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 174, 207-213 https://doi.org/10.1016/j.atherosclerosis.2004.01.024